echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Micro hot point: Hongmao pharmaceutical industry is praised? Chinese Medicine Association apologizes: recognition has been revoked

    Micro hot point: Hongmao pharmaceutical industry is praised? Chinese Medicine Association apologizes: recognition has been revoked

    • Last Update: 2019-12-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Last night, the Chinese Traditional Medicine Association issued an apology letter on its official website, saying that on December 21, 2019, in the process of issuing the report on social responsibility of Chinese traditional medicine enterprises, the association had a lot of controversial selected enterprises and individuals in the commendation process due to lax control, which caused public criticism "We have decided to cancel this recognition, correct mistakes and standardize management." Adorable adorable
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.